CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study

Journal of Child and Adolescent Psychopharmacology- United States

doi 10.1089/cap.2018.0160

Full Text

Abstract

Available in

Date

Authors

Publisher

Mary Ann Liebert Inc

Related search

Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Pharmacokinetically Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2014English

The Effect of Reporting Methods for Dosing Times on the Estimation of Pharmacokinetic Parameters of Escitalopram

Journal of Clinical Pharmacology
Pharmacology
2009English

Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Increased Omeprazole Metabolism in Carriers of the CYP2C19*17 Allele; A Pharmacokinetic Study in Healthy Volunteers

British Journal of Clinical Pharmacology
Pharmacology
2008English

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients With Pneumonia

Antibiotics
PharmacologyBiochemistryMicrobiologyToxicologyInfectious DiseasesPharmaceutics
2020English

Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2007English

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Clinical Cancer Research
Cancer ResearchOncology
2011English

Changes in BDNF Serum Levels in Patients With Major Depression Disorder (MDD) After 6 Months Treatment With Sertraline, Escitalopram, or Venlafaxine

Journal of Psychiatric Research
PsychiatryBiological PsychiatryMental Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy